As shown, most cancers were exhibited as SMAD2 positive, such as colorectal, endometrial, ovarian, renal and thyroid cancers, which indicated that SMAD2 widely expressed in a variety of cancer cells (Figure 8A). The gene discussed is SMAD2; the disease is thyroid gland carcinoma.